ProGIGuard is a specialised baker's yeast probiotic strain which scientifically helps to:

  • accelerates bowel transit, reduce bloating & constipation.

  • reduce stomach sensitivity, increase resistance to stomach pain

  • reduces intestinal pathogens such as Enterococcus, E.coli and C.albicans

 

Saccharomyces Cerevisiae CNCM I-3856

 

Scientifically Support

Saccharomyces Cerevisiae CNCM I-3856

for Digestive Health

  • Studies on more than 1700 volunteers including 600 during clinical studies

  • S.cerevisiae CNCM I-3856 is well tolerated and reduces abdominal pain/discomfort scores without stool modification.

  • S.cerevisiae CNCM I-3856 improved gastrointestinal symptoms, reduce bloating in the subgroup with IBS-C.

Saccharomyces Cerevisiae CNCM I-3856

for Vaginal Health

  • Start to take effect after the 7th day of consumption.

  • Decrease the vaginal load of Yeast candidiasis (C.albicans) and Bacteria Vaginosis (G.vaginalis).

  • Decrease the risks of recurrence of Candida infection by 54%.

  • Anti-inflammatory, relief inflammation caused by infection.

 

Why ProGIGuard?

 

A proprietary patented and exclusive healthy live baker's yeast in a clinical strain

Safe in combination with antibiotic therapy

Stable to heat, for easy storage and guaranteed efficacy

Fast acting

Studies on more than 1700 volunteers including 600 during clinical studies

Frequently asked questions

How do I take ProGIGuard?


Initial treatment: 2 capsules 2 times daily. Maintenance: 2 capsules daily Best before food, can take after meal if have very sensisitive stomach condition.




Who should take ProGIGuard?


Having candidiasis conditions such as: - IBS related symptoms: - Abdominal discomfort - Constipation - Bloating - Unsolve white discharge




How soon can I see results after taking ProGIGuard?


Digestive Health

  • 77% of consumers experienced ProGIGuard efffect within 15 days of consumption. (1)
  • 96% of consumers satisfaction. (1)
Vaginal Health
  • starts to take effect after 7 days of consumtion, 57% reduction in candida load in vaginal vs 33% in the placebo group, after second month consumption.(2)
  • decreases the risks of recurrence by 54%. It accelerates C.albicans clearance after 2 months.(2)
1. Satisfaction reported during a survey performed on 1161 volunteers. Taban J. Soigner le patient colopathe, La revue Pharma. 2015 October, 125: 44 2. July 2016: Medical Journal of Obstetrics and Gynecology Saccharomyces cerevisiae CNCM I-3856 as a natural breakthrough for vaginal health: A clinical study. Amelie Cayzeela-Decherf, Fanny Pelerin and Peter Justen.





 
 

OPERATION HOURS

Mon - Fri: 9am - 5.30pm
Sat - Sun & PH: Closed

  • Facebook Social Icon

Questions? Contact Us

Follow Our Social Media

Privacy Policy

Copyright © 2020 The PRIME by Cambert